Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Bioventus Inc BVS

Healthcare Medical Devices
Bioventus Inc. is a medical device company. The Company’s portfolio of products is grouped into three areas. Its Pain Treatments include the Knee Osteoarthritis (KOA) area, and Peripheral Nerve Stimulation (PNS) area. Its Surgical Solutions include Ultrasonics, which offers precision bone resection for patients with degenerative spine conditions and spinal deformities, and Bone Graft... see more

Recent & Breaking News (NDAQ:BVS)

Bioventus Reports Third Quarter Financial Results

GlobeNewswire 8 days ago

Bioventus to Report Third Quarter of Fiscal Year 2025 Financial Results on November 4, 2025

GlobeNewswire October 28, 2025

Halper Sadeh LLC Encourages Bioventus Inc. Shareholders to Contact the Firm to Discuss Their Rights

Business Wire October 22, 2025

Bioventus to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference

GlobeNewswire September 3, 2025

Bioventus to Present at the Canaccord Genuity 45th Annual Global Growth Conference

GlobeNewswire August 7, 2025

Bioventus Reports Second Quarter Financial Results

GlobeNewswire August 6, 2025

Bioventus Enters into a New $400 Million Senior Secured Credit Agreement Lowering Interest Expense and Providing Increased Liquidity

GlobeNewswire August 4, 2025

Bioventus Receives FDA 510(k) Clearances for two Next-Generation Peripheral Nerve Stimulation Products

GlobeNewswire July 30, 2025

Bioventus to Report Second Quarter of Fiscal Year 2025 Financial Results on August 6, 2025

GlobeNewswire July 29, 2025

Bioventus Reports First Quarter Financial Results

GlobeNewswire May 6, 2025

Bioventus to Report First Quarter of Fiscal Year 2025 Financial Results on May 6, 2025

GlobeNewswire April 28, 2025

Bioventus Announces Fourth Quarter and Full Year 2024 Financial Results

GlobeNewswire March 11, 2025

Bioventus to Report Fourth Quarter of Fiscal Year 2024 Financial Results on March 11, 2025

GlobeNewswire February 28, 2025

Bioventus to Present at the 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswire January 7, 2025

Bioventus Completes Divestiture of its Advanced Rehabilitation Business to Accelmed Partners

GlobeNewswire January 2, 2025

Bioventus Reports Third Quarter Financial Results

GlobeNewswire November 5, 2024

Bioventus to Report Third Quarter of Fiscal Year 2024 Financial Results on November 5, 2024

GlobeNewswire October 29, 2024

Bioventus Announces Divestiture of its Advanced Rehabilitation Business to Accelmed Partners

GlobeNewswire October 1, 2024

Bioventus to Present at the Canaccord Genuity 44th Annual Global Growth Conference

GlobeNewswire August 7, 2024

Bioventus Reports Second Quarter Financial Results

GlobeNewswire August 6, 2024